Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Huttunen

Showing results (101-110 of 157) with videos related to

Pageof 16
Sort By:
International Journal of Molecular Sciences|July 24, 2021
Ganciclovir and Its Hemocompatible More Lipophilic Derivative Can Enhance the Apoptotic Effects of Methotrexate by Inhibiting Breast Cancer Resistance Protein (BCRP)Magdalena Markowicz-Piasecka, Johanna Huttunen, Ahmed Montaser, et al.
Frontiers in Pharmacology|November 7, 2022
Aminopeptidase B can bioconvert L-type amino acid transporter 1 (LAT1)-utilizing amide prodrugs in the brainAgathe Hugele, Susanne Löffler, Belén Hernández Molina, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 13, 2022
Current approaches to facilitate improved drug delivery to the central nervous systemMagdalena Markowicz-Piasecka, Patrycja Darłak, Agata Markiewicz, et al.
Journal of Medicinal Chemistry|June 16, 2009
The first bioreversible prodrug of metformin with improved lipophilicity and enhanced intestinal absorptionKristiina M Huttunen, Anne Mannila, Krista Laine, et al.
Chemmedchem|February 3, 2026
A Novel Tertiary Carbamate Prodrug Strategy to Overcome Metabolic Barriers in Oral Ketamine DeliveryJuulia Järvinen, Santosh Kumar Adla, Janne Tampio, et al.
Neurochemical Research|July 15, 2016
Amino Acid Promoieties Alter Valproic Acid Pharmacokinetics and Enable Extended Brain ExposureMikko Gynther, Lauri Peura, Monika Vernerová, et al.
Molecular Pharmaceutics|November 17, 2022
Structural Features Affecting the Interactions and Transportability of LAT1-Targeted Phenylalanine Drug ConjugatesKatayun Bahrami, Juulia Järvinen, Tuomo Laitinen, et al.
International Journal of Pharmaceutics|February 4, 2021
Species differences in the intra-brain distribution of an L-type amino acid transporter 1 (LAT1) -utilizing compound between mice and ratsAaro J Jalkanen, Jouni Ihalainen, Marko Lehtonen, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 8, 2022
Current Chemical, Biological, and Physiological Views in the Development of Successful Brain-Targeted PharmaceuticsMagdalena Markowicz-Piasecka, Agata Markiewicz, Patrycja Darłak, et al.
ACS Chemical Neuroscience|November 24, 2020
L-Type Amino Acid Transporter 1 Enables the Efficient Brain Delivery of Small-Sized Prodrug across the Blood-Brain Barrier and into Human and Mouse Brain Parenchymal CellsAhmed B Montaser, Juulia Järvinen, Susanne Löffler, et al.
Pageof 16

Showing results (101-110 of 157) with videos related to

Sort By:
Pageof 16
International Journal of Molecular Sciences|July 24, 2021
Ganciclovir and Its Hemocompatible More Lipophilic Derivative Can Enhance the Apoptotic Effects of Methotrexate by Inhibiting Breast Cancer Resistance Protein (BCRP)Magdalena Markowicz-Piasecka, Johanna Huttunen, Ahmed Montaser, et al.
Frontiers in Pharmacology|November 7, 2022
Aminopeptidase B can bioconvert L-type amino acid transporter 1 (LAT1)-utilizing amide prodrugs in the brainAgathe Hugele, Susanne Löffler, Belén Hernández Molina, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 13, 2022
Current approaches to facilitate improved drug delivery to the central nervous systemMagdalena Markowicz-Piasecka, Patrycja Darłak, Agata Markiewicz, et al.
Journal of Medicinal Chemistry|June 16, 2009
The first bioreversible prodrug of metformin with improved lipophilicity and enhanced intestinal absorptionKristiina M Huttunen, Anne Mannila, Krista Laine, et al.
Chemmedchem|February 3, 2026
A Novel Tertiary Carbamate Prodrug Strategy to Overcome Metabolic Barriers in Oral Ketamine DeliveryJuulia Järvinen, Santosh Kumar Adla, Janne Tampio, et al.
Neurochemical Research|July 15, 2016
Amino Acid Promoieties Alter Valproic Acid Pharmacokinetics and Enable Extended Brain ExposureMikko Gynther, Lauri Peura, Monika Vernerová, et al.
Molecular Pharmaceutics|November 17, 2022
Structural Features Affecting the Interactions and Transportability of LAT1-Targeted Phenylalanine Drug ConjugatesKatayun Bahrami, Juulia Järvinen, Tuomo Laitinen, et al.
International Journal of Pharmaceutics|February 4, 2021
Species differences in the intra-brain distribution of an L-type amino acid transporter 1 (LAT1) -utilizing compound between mice and ratsAaro J Jalkanen, Jouni Ihalainen, Marko Lehtonen, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 8, 2022
Current Chemical, Biological, and Physiological Views in the Development of Successful Brain-Targeted PharmaceuticsMagdalena Markowicz-Piasecka, Agata Markiewicz, Patrycja Darłak, et al.
ACS Chemical Neuroscience|November 24, 2020
L-Type Amino Acid Transporter 1 Enables the Efficient Brain Delivery of Small-Sized Prodrug across the Blood-Brain Barrier and into Human and Mouse Brain Parenchymal CellsAhmed B Montaser, Juulia Järvinen, Susanne Löffler, et al.
Pageof 16